NCT00085020View on ClinicalTrials.gov

GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

February 28, 2005

Conditions

Breast Cancer

Interventions

BIOLOGICAL

trastuzumab

DRUG

lapatinib ditosylate

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER